Core Viewpoint - The company has received approval from the National Medical Products Administration for its new anti-tumor drug, JFAN-1001 mesylate capsules, which targets a specific mutation in non-small cell lung cancer [1] Group 1: Company Developments - The wholly-owned subsidiary of the company,尖峰亦恩, has been granted the Clinical Trial Approval Notice for JFAN-1001 mesylate capsules [1] - JFAN-1001 mesylate capsules are classified as a Class 1 chemical drug and are developed for the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer with EGFR-T790M secondary mutation [1]

Core Viewpoint - The company has received approval for a clinical trial of its new anti-tumor drug JFAN-1001, which targets advanced non-squamous non-small cell lung cancer patients with specific genetic mutations [1] Group 1: Company Developments - Zhejiang Jianfeng Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Jianfeng Group, has received a clinical trial approval notice from the National Medical Products Administration for JFAN-1001 mesylate capsules [1] - The clinical trial will evaluate the combination of JFAN-1001 with Tarceva (erlotinib) soft capsules in patients with advanced non-squamous non-small cell lung cancer [1] - JFAN-1001 is classified as a Class 1 chemical drug and is indicated for locally advanced or metastatic non-small cell lung cancer with EGFR-T790M secondary mutations [1] Group 2: Clinical Trial Status - The clinical trial application for JFAN-1001 was accepted on September 8, 2025, and is currently undergoing Phase II clinical trials in China [1] - The drug has also received clinical trial permission from the U.S. Food and Drug Administration [1]

浙江尖峰集团股份有限公司 2025 年第二次临时股东大会 会议资料 二〇二五年十一月 尖峰集团 2025 年第二次临时股东大会会议材料 浙江尖峰集团股份有限公司 2025 年第二次临时股东大会议程 一、会议召开形式 本次股东大会所采用现场投票和网络投票相结合的方式召开 二、现场会议召开的日期、时间、地点和召集人 召开的日期、时间：2025 年 11 月 21 日，下午 14：00； 召开地点：浙江省金华市婺江东路 88 号尖峰大厦三楼会议室。 召集人：本公司董事会 三、网络投票的系统、投票时间。 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为 股东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通 过互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 投票注意事项： (一) 本公司股东通过上海证券交易所股东大会网络投票系统行使表决权 的，既可以登陆交易系统投票平台（通过指定交易的证券公司交易终端）进行投 票，也可以登陆互联网投票平台（网址：vote.sseinfo.com）进行投票。首次登 陆互联网投票平台进行投票的，投资者需 ...

Market Overview - The cement sector increased by 0.72% on November 10, with Sichuan Jinding leading the gains [1] - The Shanghai Composite Index closed at 4018.6, up 0.53%, while the Shenzhen Component Index closed at 13427.61, up 0.18% [1] Individual Stock Performance - Sichuan Jinding (600678) closed at 12.00, up 9.99% with a trading volume of 312,000 shares and a turnover of 374 million yuan [1] - Fujian Cement (600802) closed at 7.39, up 2.21% with a trading volume of 721,200 shares and a turnover of 525 million yuan [1] - Other notable performers include Qingsong Jianhua (600425) up 1.68%, Jianfeng Group (600668) up 1.26%, and Huaxin Cement (600801) up 1.19% [1] Capital Flow Analysis - The cement sector experienced a net outflow of 20.20 million yuan from institutional investors, while retail investors saw a net inflow of 102 million yuan [2] - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are more active [2] Detailed Capital Flow for Selected Stocks - Huaxin Cement (600801) had a net outflow of 94.26 million yuan from institutional investors, while retail investors contributed a net inflow of 39.52 million yuan [3] - Sichuan Jinding (600678) saw a net inflow of 62.66 million yuan from institutional investors, but a net outflow of 33.51 million yuan from retail investors [3] - Other stocks like Conch Cement (600585) and Jianfeng Group (600668) also showed varied capital flows, indicating differing investor sentiments across the sector [3]

Market Overview - The cement sector experienced a decline of 0.2% on November 4, with Shangfeng Cement leading the drop [1] - The Shanghai Composite Index closed at 3960.19, down 0.41%, while the Shenzhen Component Index closed at 13175.22, down 1.71% [1] Individual Stock Performance - Hanjian Heshan saw a significant increase of 10.09%, closing at 6.11, with a trading volume of 231,100 shares and a turnover of 141 million yuan [1] - Fujian Cement also rose by 10.00%, closing at 7.81, with a trading volume of 706,200 shares and a turnover of 527 million yuan [1] - Conversely, Shangfeng Cement fell by 1.83%, closing at 10.74, with a trading volume of 152,300 shares and a turnover of 164 million yuan [2] Capital Flow Analysis - The cement sector had a net inflow of 68.57 million yuan from institutional investors, while retail investors saw a net outflow of 93.65 million yuan [2][3] - Notably, Fujian Cement experienced a net inflow of 102 million yuan from institutional investors, but a net outflow of 68.33 million yuan from retail investors [3] - Hanjian Heshan had a substantial net inflow of 77.89 million yuan from institutional investors, with a significant net outflow of 39.61 million yuan from retail investors [3]

Core Points - The company, Jianfeng Group, announced a share buyback program, having repurchased a total of 871,800 shares as of October 31, 2025, which represents 0.211% of its total share capital of 412,900,594 shares [2] Summary by Category - **Share Buyback Details** - The total number of shares repurchased is 871,800 [2] - This repurchase accounts for 0.211% of the company's total share capital [2] - The buyback was conducted through the Shanghai Stock Exchange's centralized bidding trading system [2] - **Company's Total Share Capital** - The total share capital of Jianfeng Group is 412,900,594 shares [2]

Core Viewpoint - The company, Jianfeng Group, has announced a share buyback program, indicating a commitment to enhancing shareholder value through capital management [1] Group 1 - As of the announcement date, the company has repurchased a total of 871,800 shares [1] - The repurchased shares represent 0.211% of the company's total share capital of 413 million shares [1] - The buyback was conducted through the Shanghai Stock Exchange's centralized bidding system [1] Group 2 - The minimum price for the repurchased shares was 11.63 yuan per share, while the maximum price was 12.27 yuan per share [1] - The total amount of funds paid for the buyback reached 10.31 million yuan, excluding transaction fees such as stamp duty and commissions [1]

证券简称：尖峰集团 证券代码：600668 编号：临 2025-058 具体内容详见公司于 2025 年 4 月 22 日、7 月 16 日在上海证券交易所网站 （www.sse.com.cn）披露的《尖峰集团关于以集中竞价交易方式回购公司股份方 1 案的公告》（临 2025-014）、《尖峰集团关于实施 2024 年年度权益分派后调整回 购股份价格上限的公告》（临 2025-034）。 二、回购股份的进展情况 浙江尖峰集团股份有限公司 关于以集中竞价交易方式回购公司股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 | 回购方案首次披露日 | 2025年4月22日 | | --- | --- | | 回购方案实施期限 | 自董事会审议通过本次回购股份方案之日起12个月内 | | 预计回购金额 | 2,000万元-4,000万元 | | 回购用途 | □减少注册资本 | | | √用于员工持股计划或股权激励 | | | □用于转换公司发行的可转换为股票的公司债券 | | | □为维护公司价值及股东权益 | | ...

证券代码：600668 证券简称：尖峰集团 公告编号：临 2025-059 浙江尖峰集团股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于 2025 年 11 月 26 日（星期三）至 12 月 02 日（星期二）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 jfjtsmh @126.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 浙江尖峰集团股份有限公司（以下简称"公司"）已于 2025 年 10 月 30 日发 布公司 2025 年第三季度报告，为便于广大投资者更全面深入地了解公司 2025 年第三季度经营成果、财务状况，公司计划于 2025 年 12 月 03 日（星期三） 15:00-16:00 举行 2025 年第三季度业绩说明会，就投资者关心的问题进行交流。 一、 说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2025 年第三季度的经 营成果及财务指标的具体情况与投资 ...

Core Viewpoint - The company, Jianfeng Group, has announced a share buyback program, indicating a commitment to returning value to shareholders and potentially signaling confidence in its future performance [1] Summary by Categories Share Buyback Details - As of the announcement date, Jianfeng Group has repurchased a total of 871,800 shares, which represents 0.211% of the company's total share capital of 413 million shares [1] - The buyback was conducted through the Shanghai Stock Exchange's centralized bidding system [1] - The lowest price for the repurchased shares was 11.63 CNY per share, while the highest price was 12.27 CNY per share [1] - The total amount of funds paid for the buyback reached 10.31 million CNY, excluding transaction fees such as stamp duty and commissions [1]